Resistencia a los antibióticos: lo que hay que saber

Se calcula que el 28 por ciento de los antibióticos recetados a niños y adultos son innecesarios. En esta temporada, aprende cómo usarlos (y cuándo es mejor evitarlos).

A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicine

An A.L.S. drug rejected by the F.D.A. made me rethink how doctors should give hope to patients.

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

In a wide-ranging interview, Dr. Monica M. Bertagnolli, the director of the National Institutes of Health, discussed drug patents, trust in science and her own experience as a cancer patient.

We Need to Rethink Our Treatment of Pain

Cutting off access to pain medication will only hurt people who are truly suffering.

As Chain Pharmacies Close, Mom-and-Pops Pick Up the Slack

Some small independent pharmacies in the city are benefiting from a decline in chain stores. But theft and low reimbursement rates are still making life hard.

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

The deal is a bet on the growing market for psychiatric and neurological drugs.

Fake Ozempic Found in U.S., F.D.A. Warns

The agency and Novo Nordisk, the company that makes Ozempic, are testing the seized medications to determine what is in them.

What to Know About Antibiotics and Antimicrobial Resistance

It’s antibiotic season. Brush up on how you should use them — and when to avoid them.

Can Ozempic and Weight Loss Drugs Treat Other Diseases?

Scientists are exploring whether the new diabetes and weight-loss drugs could also treat addiction, kidney disease and more.

We Know How to Put People on Ozempic. Do We Know How to Get Them Off It?

How informed consent about long-term prescriptions can be improved.